Home Blog Page 53

Blog

Pharma Marketing Blog

Most popular

BI Masters the Art of WOM through Its “Parrots,” er, Spokespersons

Pharma Guy - September 21, 2011

Double-Dip Viagra Patent Means No Recession for Pfizer

Pharma Guy - August 16, 2011

Pfizer’s Deceptive “Campaign Against Migraine” Tweet Deleted – Too Late!

Pharma Guy - June 6, 2012

Chantix: PR First, Launch & Ads to Follow

Pharma Guy - July 5, 2006

Specious Arguments in Favor of Rx Data Use

Pharma Guy - May 18, 2006

GSK’s “Plain Talk” Flawed

Pharma Guy - February 24, 2006

PhRMA Intern Retrospective: The Reminder Ad

Pharma Guy - April 13, 2016

New PhRMA Survey of Physicians: Are Sales Reps as “Useful” as...

Pharma Guy - March 30, 2011

Restless Brush Syndrome: Lessons for Requip Marketers

Pharma Guy - June 5, 2006

Is Pfizer Outsourcing Innovation?

Pharma Guy - April 16, 2007

1...525354...240 Page 53 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026